| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8317200 | Clinical Biochemistry | 2015 | 6 Pages |
Abstract
We have developed a highly sensitive and reproducible ELISA for measuring circulating NRGN in blood samples. Serum NRGN concentrations in acute TBI patients were significantly higher than in controls, indicating that NRGN could have utility as a circulating biomarker for acute TBI. This report provides evidence to support larger and controlled TBI clinical studies for NRGN validation and prediction of outcomes.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Jun Yang, Frederick K. Korley, Min Dai, Allen D. Everett,